GetTopicDetailResponse(id=36a4658e4a, topicName=EGFR抑制劑, introduction=EGFR抑制劑, content=null, image=null, comments=2, allHits=1011, url=https://h5.medsci.cn/topic?id=6587, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=26774, tagList=[TagDto(tagId=26774, tagName=EGFR抑制劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2118069, encodeId=09ad211806996, content=<a href='/topic/show?id=36a4658e4a' target=_blank style='color:#2F92EE;'>#EGFR抑制劑#</a>, objectTitle=【綜述】四代EGFR抑制劑, objectType=article, longId=743850, objectId=1118e43850dc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20221009/a51136b20ee840699b7d13a56898e1ae.jpg, objectUrl=/article/show_article.do?id=1118e43850dc, replyNumber=0, likeNumber=74, createdTime=2023-03-07, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1118e43850dc, moduleTitle=【綜述】四代EGFR抑制劑, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1118e43850dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1210839, encodeId=b80c1210839d3, content=<a href='/topic/show?id=36a4658e4a' target=_blank style='color:#2F92EE;'>#EGFR抑制劑#</a>研究結(jié)果顯示，攜帶EGFR擴(kuò)增變異的胃食管交界癌患者可從EGFR抑制劑治療中獲益。此外，一項(xiàng)關(guān)于EGFRi用于攜帶EGFR和/或MET擴(kuò)增的GEA患者的前瞻性試驗(yàn)正在進(jìn)行中。, objectTitle=EGFR抑制劑, objectType=topic, longId=6587, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=62, createdTime=2022-04-13, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
前往app查看評論內(nèi)容
#EGFR抑制劑#研究結(jié)果顯示，攜帶EGFR擴(kuò)增變異的胃食管交界癌患者可從EGFR抑制劑治療中獲益。此外，一項(xiàng)關(guān)于EGFRi用于攜帶EGFR和/或MET擴(kuò)增的GEA患者的前瞻性試驗(yàn)正在進(jìn)行中。
